Company intelligence / Profile preview

Read-Gene

Szczecin, West Pomeranian, Poland

Ownership: Private
Employees: ~30
Development stage: Other

Overview

Read-Gene is a Polish biotechnology company specializing in cancer genetics and personalized medicine. Founded by Professor Jan Lubiński, the company focuses on identifying genetic predispositions to various cancers and developing chemoprevention strategies, particularly involving microelements like selenium and arsenic. Read-Gene provides advanced genetic testing services, clinical trial management, and specialized dietary supplements tailored to an individual's genetic profile. The company operates a specialized laboratory and maintains a strong academic partnership with the Pomeranian Medical University in Szczecin.

Therapeutic areas: Oncology
Modalities: Small moleculeDiagnostic test
Industry: Biotech

Partnerships

Pomeranian Medical University

Beyond the preview

Go deeper on Read-Gene.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Read-Gene.

Explore the full profile